Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Lidocaine Decreases Postoperative Lung Cancer Reoccurance and Metatasis Risk	Disease Attributes, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Recurrence, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm	Not yet recruiting	Not applicable	2026-01-16		NCT07347977

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
First Affiliated Hospital of Ningbo University	44
Ningbo Medical Center Lihuili Hospital	61
Second Affiliated Hospital of Wenzhou Medical University	81
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University	28

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
The First Affiliated Hospital of Ningbo University	Ningbo	China	12